Anavex Life Sciences Corp. is Initiated by Noble Financial to “Buy”

Anavex Life Sciences Corp. (AVXL) was Initiated by Noble Financial to “Buy” and the brokerage firm has set the Price Target at $16. Noble Financial advised their Clients and Investors in a research report released on Feb 7, 2017.

Several company insiders have filed Insider transactions , on Jul 14, 2015, Christopher U Missling (CEO) purchased 1,000 shares at $0.52 per share price.

Anavex Life Sciences Corp. closed down -0.03 points or -0.52% at $5.72 with 9,56,624 shares getting traded on Friday. Post opening the session at $5.77, the shares hit an intraday low of $5.61 and an intraday high of $5.9 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

Anavex Life Sciences Corp.

Leave a Reply

Anavex Life Sciences Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Anavex Life Sciences Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.